How many years can you live taking Dasatinib?

Dasatinib (Dasatinib) is a drug used to treat certain types of leukemia. Everyone's condition and survival are different, so it's difficult to accurately predict how long someone will live on dasatinib. For patients with leukemia, dasatinib can help control disease progression, extend survival, and improve quality of life. But this depends on many factors, including the severity of the condition, the patient's overall health and the effectiveness of other treatment options.

A clinical study analyzed the longest follow-up report of the second-generationBCR-ABL inhibitor dasatinib in patients with chronic myeloid leukemia in the chronic phase. The findings suggest that a persistent subgroup of patients with CML-CP who are resistant or intolerant to imatinib may derive long-term benefit from dasatinib treatment. In particular, those patients who had a faster and deeper response to dasatinib (BCR-ABL ≤10% at 3 months) were more likely to have better long-term outcomes. The 6-year progression-free survival (PFS) rate ranged from 40% to 51% across treatment groups and was 49% in the 100 mg once-daily group. Six-year OS rates were similar between groups (70% vs. 77%). At 6 years, 31% of patients were still receiving study treatment at 100 mg once daily.

The original drug of dasatinib has been launched in China and is included in the medical insurance. Currently, reimbursement is only available to eligible patients. Common specifications The price of each box of 50mg*60 tablets may be around RMB 10,000. The original drug overseas is even more expensive. Dasatinib generics are also sold overseas. The ingredients of the drug are basically the same as those sold domestically and abroad, but the price is cheap. For example, the price of a box of 50mg*60 tablets produced by an Indian pharmaceutical factory may be several hundred yuan (the price may fluctuate due to exchange rates).